Vaccine News and Research

Latest Vaccine News and Research

Los Angeles health officials urge public to take preventative measures against West Nile virus

Los Angeles health officials have issued a statement urging the public to take precautions against mosquitoes after crows in the county tested positive for the West Nile virus. "These findings are a clear warning that the virus is continuing to circulate and amplify in the environment. Now is the time to take precautions," said Steve West of the San Gabriel Valley Mosquito and Vector Control District.

24 Apr 2004

Overview of West Nile virus before season starts

West Nile virus is a newly emergent virus of the family Flaviviridae, found in both tropical and temperate regions. It mainly infects birds, but is also the cause of a number of conditions in humans, horses, and some other mammals. It is transmitted by bites of infected mosquitoes.

24 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

Research may offer potent vaccines for viruses such as HIV and West Nile

Researchers at La Jolla Institute for Allergy & Immunology (LIAI) have identified two molecules (TL and CD8aa) that cooperate to trigger immune cells to develop into long-lived memory cells to fight recurring infections. This finding may have important implications for the future development of longer lasting and more potent vaccines for viruses such as HIV and West Nile.

23 Apr 2004

Hepatitis B vaccination for inmates

rrectional settings provide a unique opportunity to offer hepatitis B vaccination to a substantial number of high-risk adults who are willing to be vaccinated and who would not otherwise have access to the preventive medicine, according to a new Brown University study of inmates within the Rhode Island Department of Corrections.

23 Apr 2004

No relationship between HIV and oral polio vaccine

HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist

21 Apr 2004

PAHO's revolving fund for immunization

A quarter century ago, the Pan American Health Organization (PAHO) and its member countries launched a unique procurement and financing mechanism to buy vaccines, syringes, and "cold chain" equipment – the basic components of their immunization programs.

21 Apr 2004

One woman’s efforts to eliminate health disparities

In 1970, Mulva Pearson, MD, then 10 years old, left her home country of Jamaica with just the clothes on her back – not even a suitcase. Her destination: the United States, where her mother had been living in search of a better job and better life for her family.

21 Apr 2004

A promising new therapy for rheumatoid arthritis

A promising new therapy for rheumatoid arthritis (RA) developed by researchers at the University of California, San Diego (UCSD) School of Medicine re-educates the body's immune system to prevent an attack against healthy joint tissue.

21 Apr 2004

Surviving pneumonia may only provide a short-term lease on a future healthy life

Researchers have shown that the subsequent 2 to 3 years after discharge from the hospital following treatment for pneumonia may provide only a short-term lease on a future healthy life if the patient has certain significant and independent predictors of mortality.

20 Apr 2004

Can public health promotion beat disease?

Huge efforts are under way to address health problems such as SARS, HIV, diabetes and many other illnesses by developing vaccines or therapeutic drugs.

20 Apr 2004

Dietary supplement may improve immune function in the elderly

A recent clinical study has demonstrated that 7-oxo Dehydroepiandrosterone taken orally twice daily by healthy adults over a period of one month augments several key T-cell mediated immune function parameters compared to placebo administration.

20 Apr 2004

An experimental vaccine based on a critical piece of the SARS virus

An experimental vaccine based on a critical piece of the SARS virus protects mice from SARS infection, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found.

19 Apr 2004

Bladder cancer is the fourth most common cancer in men and the eighth most common in women

Bladder cancer is the fourth most common cancer in men and the eighth most common in women, according to the National Cancer Institute (NCI). It is expected to be diagnosed in 38,000 men and 15,000 women in the United States in 2003. Treatment is most successful when the disease is caught early.

18 Apr 2004

New diagnostic test for latent tuberculosis introduced

The Tuberculin skin test, used to detect latent Mycobacterium tuberculosis infection, has many drawbacks and a new diagnostic test for latent tuberculosis (QuantiFERON®-TB) has recently been introduced.

17 Apr 2004

Measles outbreak prompts CDC to recommend suspension of adoptions from Chinese orphanage

The Centers for Disease Control and Prevention (CDC) today recommended a temporary suspension of adoption proceedings for children from the Zhuzhou Child Welfare Institute in the Hunan Province of China, which is experiencing an outbreak of measles.

16 Apr 2004

New insights into how tumors neutralize CD8 T cells

Scientists have speculated that this may be because the immune response is not strong enough, or because it does not last long enough to have an effect. Hence the increasing efforts to develop cancer vaccines that induce, strengthen, and increase the duration of immunological attack against cancer cells.

16 Apr 2004

Cancer-specific protein offers new target for the development of melanoma vaccine

Scientists from the Cancer Vaccine Collaborative (CVC) have discovered that the cancer-specific protein, SSX-2, induces a spontaneous immunological reaction against cancer cells in melanoma patients, offering a new target for the development of a therapeutic melanoma vaccine. SSX-2 is the prototype of the SSX family, and is part of a larger group of proteins known as cancer/testis (CT) antigens.

16 Apr 2004

HIV Vaccine Program to Lead Local Efforts

May 18 has been designated HIV Vaccine Awareness Day, a day to educate Americans about the need for a vaccine to prevent HIV. This year's theme is "Real People. Real Progress." Thousands of study volunteers, scientists, and health care professionals are committed to finding a safe and effective vaccine.

15 Apr 2004

Autism Associations shows CDC and FDA to be negligent

National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.

14 Apr 2004

Vaccine News and Research

Latest Vaccine News and Research

Los Angeles health officials urge public to take preventative measures against West Nile virus

Overview of West Nile virus before season starts

Severe Acute Respiratory Syndrome (SARS) overview

Research may offer potent vaccines for viruses such as HIV and West Nile

Hepatitis B vaccination for inmates

No relationship between HIV and oral polio vaccine

PAHO's revolving fund for immunization

One woman’s efforts to eliminate health disparities

A promising new therapy for rheumatoid arthritis

Surviving pneumonia may only provide a short-term lease on a future healthy life

Can public health promotion beat disease?

Dietary supplement may improve immune function in the elderly

An experimental vaccine based on a critical piece of the SARS virus

Bladder cancer is the fourth most common cancer in men and the eighth most common in women

New diagnostic test for latent tuberculosis introduced

Measles outbreak prompts CDC to recommend suspension of adoptions from Chinese orphanage

New insights into how tumors neutralize CD8 T cells

Cancer-specific protein offers new target for the development of melanoma vaccine

HIV Vaccine Program to Lead Local Efforts

Autism Associations shows CDC and FDA to be negligent

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Vaccine News and Research

Latest Vaccine News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in